Pharmacokinetics of orally-administered Nicotinamide Powder 10% Zonne and its NAD+ pathway metabolites
Phase 1
- Conditions
- ot applicable
- Registration Number
- JPRN-UMIN000031610
- Lead Sponsor
- Hamamatsu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 8
Inclusion Criteria
Not provided
Exclusion Criteria
1. Those who take supplements containing vitamin B3 and wish to continue during the trial. 2. Those who are potentially pregnant. 3. Those who are under lactation. 4. Those who are under treatment. 5. Those judged by doctors or researchers to be inappropriate to participation in research.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pharmacokinetics of NAD+ in the blood and urine following the single administration of the drug
- Secondary Outcome Measures
Name Time Method Pharmacokinetics of nicotinamide in the blood and urine following the single administration of the drug Safety evaluation with liver function monitoring